Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PCM1-JAK2 Fusion Gene Detection in Patients With Therapy Related Myelodysplastic Syndrome / Acute Myeloid Leukemia Patients

NCT03943394 is registered in ClinicalTrials.gov with Assiut University as lead sponsor.

NCT NCT03943394
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03943394 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PCM1-JAK2 Fusion Gene Detection in Patients With Therapy Related Myelodysplastic Syndrome / Acute Myeloid Leukemia Patients
Lead sponsor
Assiut University
Phase
Observational
Overall status
Unknown status
Start date
June 30, 2019
Completion date
June 30, 2022
Enrollment
140 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

detection of pcm1-jak2 fusion gene by fish in the two types of t-mds/aml and relationship between pcm1-jak2 fusion gene and cumulative dose, dose intensity